Increased in vivo frequency of IA-2 peptide-reactive IFNgamma+/IL-4- T cells in type 1 diabetic subjects.
about
How frequently are predicted peptides actually recognized by CD8 cells?T cell epitopes and post-translationally modified epitopes in type 1 diabetesELISPOT Assays in 384-Well Format: Up to 30 Data Points with One Million Cells.Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8.Reagent Tracker Dyes Permit Quality Control for Verifying Plating Accuracy in ELISPOT Tests.T cell epitope mapping study with insulin overlapping peptides using ELISPOT assay in Japanese children and adolescents with type 1 diabetes.
P2860
Increased in vivo frequency of IA-2 peptide-reactive IFNgamma+/IL-4- T cells in type 1 diabetic subjects.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Increased in vivo frequency of ...... s in type 1 diabetic subjects.
@ast
Increased in vivo frequency of ...... s in type 1 diabetic subjects.
@en
type
label
Increased in vivo frequency of ...... s in type 1 diabetic subjects.
@ast
Increased in vivo frequency of ...... s in type 1 diabetic subjects.
@en
prefLabel
Increased in vivo frequency of ...... s in type 1 diabetic subjects.
@ast
Increased in vivo frequency of ...... s in type 1 diabetic subjects.
@en
P2093
P1476
Increased in vivo frequency of ...... s in type 1 diabetic subjects.
@en
P2093
Alexey Y Karulin
Bernhard A Herzog
Bernhard O Boehm
Ivana Durinovic-Belló
Magdalena Tary-Lehmann
Marcus T Dittrich
Patrick A Ott
Paul V Lehmann
Stefan Quast
Wolfram Karges
P356
10.1016/J.JAUT.2004.03.009
P577
2004-08-01T00:00:00Z